Medical device major, Medtronic plc MDT recently received the U.S. FDA 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. The device is an advanced cardiac ...

NICE, FRANCE – A small usability study testing a miniaturized implanted cardiac monitoring system (Reveal LINQ, Medtronic) in European patients shows the device successfully resulted in the wireless ...

BRAMPTON, ON-- Medtronic of Canada today announced it has received Health Canada license for the Reveal LINQ Insertable Cardiac Monitor (ICM), the smallest implantable cardiac monitoring device ...

Parkridge Medical Center Tuesday announced that it is one of the first hospitals in Tennessee to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor System in a patient, the smallest ...

Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke DUBLIN, Medtronic plc today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of ...

AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM MedTech Breakthrough, an independent market intelligence organization ...

The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...

Medtronic's Reveal Linq wireless cardiac monitoring implant--Courtesy of Medtronic The world's smallest cardiac monitor implant is on track to make a move into the ...

On March 13, 2017, Medtronic announced FDA 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitor (ICM) with TruRhythm Detection. Previously, Medtronic received Ministry of Health, Labor and ...

MINNEAPOLIS - February 19, 2014-Medtronic, Inc. (MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of its Reveal ...